Journal of Applied Physiology AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 89: 1293-1301, 2000;
8750-7587/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (51)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grassi, B.
Right arrow Articles by Gladden, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grassi, B.
Right arrow Articles by Gladden, L. B.
Vol. 89, Issue 4, 1293-1301, October 2000

Role of convective O2 delivery in determining VO2 on-kinetics in canine muscle contracting at peak VO2

Bruno Grassi1, Michael C. Hogan2, Kevin M. Kelley3, William G. Aschenbach3, Jason J. Hamann3, Ronald K. Evans3, Robin E. Patillo3, and L. Bruce Gladden3

1 Istituto di Tecnologie Biomediche Avanzate, Consiglio Nazionale delle Ricerche, I-20090 Segrate (MI), Italy; 2 Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0623; and 3 Department of Health and Human Performance, Auburn University, Auburn, Alabama 36849-5323


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

A previous study (Grassi B, Gladden LB, Samaja M, Stary CM, and Hogan MC, J Appl Physiol 85: 1394-1403, 1998) showed that convective O2 delivery to muscle did not limit O2 uptake (VO2) on-kinetics during transitions from rest to contractions at ~60% of peak VO2. The present study aimed to determine whether this finding is also true for transitions involving contractions of higher metabolic intensities. VO2 on-kinetics were determined in isolated canine gastrocnemius muscles in situ (n = 5) during transitions from rest to 4 min of electrically stimulated isometric tetanic contractions corresponding to the muscle peak VO2. Two conditions were compared: 1) spontaneous adjustment of muscle blood flow (Q) (Control) and 2) pump-perfused Q, adjusted ~15-30 s before contractions at a constant level corresponding to the steady-state value during contractions in Control (Fast O2 Delivery). In Fast O2 Delivery, adenosine was infused intra-arterially. Q was measured continuously in the popliteal vein; arterial and popliteal venous O2 contents were measured at rest and at 5- to 7-s intervals during the transition. Muscle VO2 was determined as Q times the arteriovenous blood O2 content difference. The time to reach 63% of the VO2 difference between resting baseline and steady-state values during contractions was 24.9 ± 1.6 (SE) s in Control and 18.5 ± 1.8 s in Fast O2 Delivery (P < 0.05). Faster VO2 on-kinetics in Fast O2 Delivery was associated with an ~30% reduction in the calculated O2 deficit and with less muscle fatigue. During transitions involving contractions at peak VO2, convective O2 delivery to muscle, together with an inertia of oxidative metabolism, contributes in determining the VO2 on-kinetics.

gas-exchange kinetics; skeletal muscle oxidative metabolism; maximal contractions


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

IN THE ISOLATED DOG GASTROCNEMIUS in situ, during transitions from rest to contractions corresponding to ~60% of the muscle peak oxygen uptake (VO2 peak), convective O2 delivery to muscle and peripheral O2 diffusion do not represent limiting factors for the kinetics of adjustment of muscle oxygen uptake (VO2) (VO2 on-kinetics) (9, 10). These findings appear to be in agreement with the hypothesis that the limiting factors for VO2 on-kinetics mainly reside in an inertia of skeletal muscle oxidative metabolism (4, 5, 21, 31). Evidence obtained in exercising humans, however, seems to indicate that, for exercises higher than the "ventilatory threshold," O2 delivery to muscle may represent a limiting factor for the VO2 on-kinetics, at variance with observations for exercise of lower metabolic intensities (8, 19). To examine this discrepancy, we conducted the present study utilizing the isolated dog gastrocnemius in situ preparation: the aim of the study was to evaluate the role of convective O2 delivery to muscle as a limiting factor for VO2 on-kinetics during transitions from rest to contractions of higher metabolic intensities (i.e., at the muscle VO2 peak) compared with those in previous work by our laboratory (9). As in the previous study (9), any delay in the kinetics of convective O2 delivery during the transition was eliminated by keeping blood flow (Q) constantly elevated at rest and throughout the contraction period. We hypothesized that, if muscle VO2 on-kinetics were limited by the rate of adjustment of convective O2 delivery, the elimination of any delay in the latter would allow faster VO2 on-kinetics to be observed.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The study was conducted with approval of the Institutional Animal Care and Use Committee of Auburn University, Auburn, Alabama, where the experiments were performed.

Five adult mongrel dogs of either sex [17.4 ± 1.5 (SE) kg body wt] were anesthetized with pentobarbital sodium (30 mg/kg), with maintenance doses given as required. The dogs were intubated with an endotracheal tube and ventilated with a respirator (model 613, Harvard Apparatus). The rectal temperature was maintained at ~37°C with a heating pad and a heating lamp. After surgical preparation, the animals were treated with heparin (2,000 U/kg). Ventilation was maintained at a level that produced normal arterial PO2 and PCO2 values.

Surgical preparation. The gastrocnemius-plantaris-flexor digitorum superficialis muscle complex (for convenience referred to as "gastrocnemius") was isolated as described previously (26). Briefly, a medial incision was made through the skin of the left hindlimb from midthigh to the ankle. The sartorius, gracilis, semitendinosus, and semimembranosus muscles, which overlie the gastrocnemius, were doubly ligated and cut between the ties. To isolate the venous outflow from the gastrocnemius, all of the vessels draining into the popliteal vein, except those from the gastrocnemius, were ligated. The popliteal vein was cannulated, and Q was measured with a 3-mm cannulating-type electromagnetic flowmeter (model RT-500, Narco Biosystems). Venous outflow was returned to the animal via a reservoir attached to a cannula in the left jugular vein. The arterial circulation to the gastrocnemius was isolated by ligation of all vessels from the femoral and popliteal artery that did not enter the gastrocnemius. The right femoral artery was also isolated and cannulated. Blood from this artery was passed through tubing to a roller pump (model 7520-25, head model 7016-20, Cole-Parmer Masterflex) and then through another cannula into the contralateral, isolated popliteal artery supplying the gastrocnemius. Y connectors positioned before and after the pump allowed either spontaneous perfusion of the gastrocnemius at the animal's own blood pressure or controlled Q at any desired level by adjustment of the pump setting. A T connector in the tubing to the gastrocnemius was connected to a pressure transducer (model RP-1500, Narco Biosystems) for measurement of muscle perfusion pressure. Arterial blood samples were taken from another T connector in the cannula exiting the right femoral artery before the roller pump.

A portion of the calcaneus, with the two tendons from the gastrocnemius attached, was cut away at the heel and clamped around a metal rod for connection to an isometric myograph via a load cell (Interface SM-250) and a universal joint coupler. The universal joint allowed the muscle always to pull directly in line with the load cell and thus prevented the application of torque to the load cell. The other end of the muscle was left attached to its origin; both the femur and the tibia were fixed to the base of the myograph by bone nails. A turnbuckle strut was placed parallel to the muscle between the tibial bone nail and the arm of the myograph to minimize flexing of the myograph.

The sciatic nerve was exposed and isolated near the gastrocnemius. The distal stump of the nerve, ~1.5-3.0 cm in length, was pulled through a small epoxy electrode containing two wire loops for stimulation. The muscle was covered with saline-soaked gauze and a thin plastic sheet to prevent drying and cooling.

Experimental design. To evoke muscle contractions, the nerve was stimulated by supramaximal square pulses of 4.0- to 6.0-V amplitude and 0.2-ms duration (Grass S48 stimulator) and isolated from ground by a stimulus isolator (Grass SIU8TB). Before each experiment, the muscle was set at optimal length by progressively lengthening the muscle as it was stimulated, at a rate of 0.2 Hz until a peak in developed tension (total tension - resting tension) was obtained. For the experiments, isometric tetanic contractions were triggered by stimulation with trains of stimuli (4-6 V, 200-ms duration, 50-Hz frequency) at a rate of 1 contraction/s for a 4-min period. Prior studies (1, 16) have shown that this stimulation pattern elicits peak metabolic rate for this muscle. Tetanic contractions were chosen to allow a rapid attainment of a steady state of developed force. A steady state of force was in fact reached from the very first contraction. For the purposes of the study, it was critical to obtain truly "rectangular" increases in the forcing function, represented by the developed force. Each isometric tetanic contraction lasted 200 ms and was separated from the following by 0.8 s, during which the muscle was relaxing or relaxed.

For each dog, the experiment consisted of two contraction periods of 4-min duration preceded by a resting baseline. The contraction periods were separated by at least 45 min of rest. The resting baseline was chosen (vs. a baseline of lower metabolic intensity) to increase the gain of the metabolic transition, thus improving the signal-to-noise ratio of the investigated variables. The investigated metabolic transition was, therefore, a rest-to-maximal contractions transition. Two conditions were compared: 1) spontaneous adjustment of self-perfused Q [control condition, spontaneous Q (Control)], and 2) pump-perfused constant Q, which was adjusted ~15-30 s before the start of contractions to a level corresponding to the steady-state value obtained during contractions in Control ["treatment" condition, characterized by a faster adjustment of O2 delivery to the gastrocnemius (Fast O2 Delivery)]. A schematic representation of the experimental protocol is shown in Fig. 1. The order of treatments could not be randomized, since in order to choose the Q level during Fast O2 Delivery it was necessary to know the "spontaneous" Q level at steady state during contractions. When the blood supply to the gastrocnemius was switched from self-perfused to pump perfused, enough time was allowed for the hemodynamic parameters to stabilize.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of the experimental protocol in Control and Fast O2 Delivery conditions. Q, blood flow; Q · arterial O2 content (CaO2), O2 delivery to muscle; a, baseline value; b, amplitude of function between baseline and steady-state values during contractions; a + b, steady-state values during contractions; vertical dashed lines, contraction onset. See text for further details.

In Fast O2 Delivery, to prevent vasoconstriction and excessive pressure increases with the elevated Q, 1-2 ml/min of a 10-2 M adenosine solution (in normal saline) were infused intra-arterially by a pump, beginning from ~15-30 s before the onset of contractions. The adenosine infusion was then continued throughout the contraction period. This dosage of the drug was previously shown to be effective, in the same preparation as the present study, in obtaining a significant vasodilation at the muscle level without causing significant metabolic effects (such as changes in resting VO2, VO2 at the same submaximal level of contraction, and VO2 peak) (9, 17).

At the end of the experiment, the dogs were killed with an overdose of pentobarbital. The gastrocnemius was excised and weighed, and the weight was utilized to normalize variables per unit of muscle mass as appropriate.

Measurements. Output from the pressure transducer was recorded on a strip-chart recorder, whereas outputs from the load cell and flowmeter were fed through strain-gauge and transducer couplers, respectively, into a computerized (PowerComputing PowerBase 240 Macintosh clone) data-acquisition system (GW Instruments, SuperScope II and instruNet model 100B D/A input/output system). The load cell reaches 90% of full response within 1 ms, whereas the flowmeter has a pulsatile cutoff frequency of 30 Hz; both signals were sampled at a rate of 100 Hz by the computerized data-acquisition system. The load cell was calibrated with known weights before each experiment. The flowmeter was calibrated with a graduated cylinder and clock during and after each experiment. Muscle Q was averaged over every five contractions and then fit to a smooth curve to allow precise calculation of Q values corresponding to the time of venous samples, as described below. Vascular resistance was calculated as muscle perfusion pressure (BPm)/Q.

Samples of arterial blood entering the muscle and of venous blood from the popliteal vein were drawn anaerobically in heparinized syringes. Because the arterial values varied only slightly throughout each experiment, arterial samples were taken at rest, before the contractions, and immediately after the contraction periods. A polyethylene tube (0.8-mm ID, 37-cm length, 0.25-ml total volume including luer hub) was threaded into the popliteal vein cannula to the point at which the vein exited the gastrocnemius. This allowed collection of venous blood immediately draining from the muscle. Venous samples were taken at rest (~10 s before the onset of contractions), every 5-7 s during the first 75 s of contractions, and every 30-45 s thereafter until the end of the contraction period. The precise time of each venous sample was recorded.

Blood samples were immediately stored in ice and analyzed within 30 min of collection. Both arterial and venous blood samples were analyzed at 37°C for PO2, PCO2, and pH by a blood-gas pH analyzer (IL 1304, Instrumentation Laboratories), and for Hb concentration and percent saturation of Hb with a CO-oximeter (IL 282, Instrumentation Laboratories) set for dog blood. These instruments were calibrated before and during each experiment. Blood O2 concentration was calculated by also taking into account the dissolved O2.

VO2 of the gastrocnemius was calculated by the Fick principle as VO2 = Q · (CaO2 - CvO2), where CaO2 - CvO2 is the difference in O2 content between arterial blood (CaO2) and venous blood (CaO2). VO2 was calculated at discrete time intervals corresponding to the timing of the blood samples.

Statistical analyses. Values are expressed as means ± SE. To check the statistical significance of differences between two means, we performed paired Student's t-test (2-tailed). The level of significance was set at P < 0.05. Data fitting by exponential or polynomial functions was performed by the squared residuals method.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The mean weight of the gastrocnemius muscles was 75 ± 5 g.

Resting values of the main variables pertinent to O2 transport and utilization, acid-base status, and hemodynamics are shown in Table 1. Arterial Hb concentration, arterial PO2, arterial Hb saturation, CaO2, arterial PCO2, and arterial pH were not significantly different between the two conditions, thereby excluding any significant ordering effect on these variables deriving from the sequence of experimental conditions. As planned, Q and Q · CaO2 were higher in Fast O2 Delivery compared with Control. However, CaO2 - CvO2 was lower in Fast O2 Delivery than in Control so that resting VO2 was not significantly different between the two conditions. BPm was not different between the two conditions. As a consequence of the adenosine infusion, muscle vascular resistance (BPm/Q) was lower in Fast O2 Delivery compared with Control.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Resting average values for the main variables pertinent to O2 transport and utilization, acid-base status, and hemodynamics in the 2 experimental conditions

Steady-state values during contractions for the main variables pertinent to O2 transport and utilization, acid-base status, and hemodynamics are shown for the two experimental conditions in Table 2. For variables related to O2 transport and utilization and acid-base status, no significant differences were observed between experimental conditions. It is noteworthy that the VO2 values were not different between the two conditions, excluding any ordering effect for this variable as well. BPm was slightly higher in Fast O2 Delivery than in Control. Muscle force values (average values calculated over 5 contractions) at the beginning of the contraction period, after 1 min of contractions, and at the end of contractions were, respectively, 4.85 ± 0.38, 3.67 ± 0.31, and 3.09 ± 0.15 N/100 g in Control and 4.41 ± 0.36, 3.87 ± 0.23, and 3.27 ± 0.17 N/100 g in Fast O2 Delivery. The fatigue index, calculated as the ratio between measured force and initial force, was after 1 min of contractions 0.76 ± 0.04 (Control) and 0.89 ± 0.03 (Fast O2 Delivery) (P < 0.05) and at the end of contractions 0.64 ± 0.03 (Control) and 0.75 ± 0.03 (Fast O2 Delivery) (P < 0.05). A higher fatigue index value indicates less muscle fatigue.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Steady-state values during contractions for the main variables pertinent to O2 transport and utilization, acid-base status, and hemodynamics in the 2 experimental conditions

Average values (± SE) of Q, CaO2 - CvO2, and VO2 at rest and during contractions in the two experimental conditions are shown in Fig. 2. As planned (see METHODS), in Fast O2 Delivery Q was kept substantially constant throughout the experiment at a level corresponding to the steady-state value observed during contractions in Control. CaO2 - CvO2 on-kinetics appeared slightly faster in Control than in Fast O2 Delivery, whereas the opposite was true for VO2 on-kinetics.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Average values (±SE) of muscle Q, arteriovenous O2 content difference (CaO2 - CvO2), and muscle O2 uptake (VO2) at rest and during contractions in the 2 experimental conditions: spontaneous adjustment of Q (Control) and pump-perfused Q adjusted ~15-30 s before start of contractions at the steady-state value during contractions in Control, i.e., with a faster adjustment of O2 delivery (Fast O2 Delivery). Vertical dashed lines, contraction onset. See text for further details.

Individual values of VO2 in the two experimental conditions are shown in Fig. 3. Because amplitudes of responses were slightly different within each dog in the two experimental conditions, to facilitate visual comparison of time courses VO2 values were "normalized" so that they ranged from 0 (time 0, resting values just before onset of contractions) to 1 (end of contractions). Visual inspection of data suggested, in most experiments, the presence of a "slow component" of VO2 kinetics (6) of delayed onset (1-2 min into the contraction period) and superimposed on the "earlier" VO2 response ("primary component," according to commonly utilized terminology, see, e.g., Ref. 32). The presence of a VO2 slow component was confirmed in 9 experiments out of 10 (the only exception being dog 3, Fast O2 Delivery, see Fig. 3) by the observation of a lower sum of squared residuals after the data were fitted with a function with two exponential terms [one for the primary (p) and one for the slow (s) component], compared with that obtained by utilizing a monoexponential function. Thus to evaluate mathematically and compare the VO2 on-kinetics in the two experimental conditions, values obtained for each experiment during the contraction period (as well as the value corresponding to time 0, i.e., the resting value) were fitted by a function of the type
y(t)=a+bp·[1−e<SUP>−(<IT>t − cp</IT>)<IT>/dp</IT></SUP>]<IT>+bs·</IT>[<IT>1−e</IT><SUP> − (<IT>t − cs</IT>)<IT>/ds</IT></SUP>] (1)
where t is time, a is baseline value, bp is the amplitude between a and steady-state value during the primary component (a bp), bs is the amplitude between a + bp and the steady-state value during the slow component, cp and cs are the time delays (TDs), and dp and ds are the time constants (tau ) of the functions during the two components of the response. Parameter values (cp, cs, dp, ds) were determined that yielded the lowest sum of squared residuals.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   Individual VO2 values at rest and during contractions in the 2 experimental conditions. Data were normalized, [value at time x - resting value (r)]/{value at the end of contractions [steady state (ss)] - r} so that they ranged from 0 (time 0, resting values just before onset of contractions) to 1 (values at the end of contractions). The curves described by the functions that yielded the lowest values of squared residuals (primary component) are also shown. Dotted lines indicate the asymptotes of the primary component of the VO2 response. See text for further details.

In dog 3, Fast O2 Delivery (experiment in which no slow component was observed) VO2 data were fitted by a monoexponential function of the type
y(t)=a+bp·[1−e<SUP>−(<IT>t − cp</IT>)<IT>/dp</IT></SUP>] (2)
The curves described by the resulting functions are shown for each experiment in Fig. 3, together with the experimental points. Toward the end of the contraction period, VO2 had reached an asymptote. In fact, differences between the last and the penultimate VO2 data points amounted to 0.12 ml · min-1 · 100 g-1 in Control and to 0.04 ml · min-1 · 100 g-1 in Fast O2 Delivery, corresponding in both cases to <1% of the total VO2 response. Amplitudes of the VO2 slow component were not significantly different in Fast O2 Delivery (1.3 ± 0.5 ml · min-1 · 100 g-1) and Control (1.1 ± 0.2 ml · min-1 · 100 g-1).

To compare the VO2 on-kinetics in the two experimental conditions, Eq. 1 or 2 was solved to calculate the time necessary to reach 50% (t50%, corresponding to the half-time of the overall response) and 63% [t63%, corresponding to the "mean response time" (14) or to the tau  of a monoexponential response] of the differences between the resting baselines and the steady-state values obtained during contractions. The resulting times correspond to the points at which the VO2 response passed through 50 and 63% of the difference between the resting baseline and steady state toward the end of contractions (9, 10, 12). In all experiments, t50% and t63% occurred during the primary component of the VO2 on-kinetics. Both t50% and t63% were calculated to allow an easier comparison with previous studies, which utilized either half-time or tau  (or mean response time) to describe the VO2 on-kinetics. The obtained average values (±SE) of t50% and t63% for the two experimental conditions are shown in Fig.4.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Average values (±SE) of calculated times to reach 50% (t50%) and 63% (t63%) of differences between resting baselines and steady-state values obtained toward the end of contractions for the VO2 on-kinetics in the 2 experimental conditions. * P < 0.05. See text for further details.

A slow component was also observed for Q in Control (amplitude 7.0 ± 2.4 ml · 100 g-1 · min-1) and for CaO2 - CvO2 in Fast O2 Delivery (amplitude 0.7 ± 0.2 ml · 100 g-1 · min-1). Equation 1 was, therefore, utilized to fit these data. On the other hand, because no slow component was observed for CaO2 - CvO2 in Control, Eq. 2 was utilized to fit the latter data. No kinetics analysis could, of course, be performed for Q in Fast O2 Delivery (the variable was kept constant throughout the test). TDs and tau  for the primary component (TDp and tau p, respectively) were calculated for VO2, Q, and CaO2 - CvO2, and the obtained values are presented in Table 3. In Control, Q increased almost immediately at contraction onset (TDp < 0.5 s) with an exponential time course characterized by a tau p of ~25 s, whereas, for CaO2 - CvO2, a very rapid exponential increase, characterized by a tau p of ~6 s, was preceded by an ~6.5 s TDp. Also for VO2, an exponential increase with a tau p of ~17 s was preceded by TDp of ~6 s. The sum of TDp and tau p was not different between Q and VO2, whereas values for CaO2 - CvO2 were significantly lower. TDp and tau p for VO2 were both significantly lower in Fast O2 Delivery than in Control, showing that the faster VO2 on-kinetics in the former were attributable to a faster primary component. The tau p for CaO2 - CvO2 was significantly higher in Fast O2 Delivery than in Control.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Kinetics parameters for the primary responses of VO2, Q, and CaO2 - CvO2 in the 2 experimental conditions

The "O2 deficit" for the investigated on-transition, i.e., the time integral of the difference between the O2 requirement (considered, as a first approximation, corresponding to the asymptotic VO2 value during the slow component) and the measured VO2, was calculated for the two experimental conditions as the product between the overall amplitude of the response (i.e., the VO2 difference between the resting baseline and the asymptotic value during the slow component) and t63% (taken as a mean response time for the non-steady-state VO2 changes) (32). The O2 deficit was 6.4 ± 0.6 ml/100 g in Control and 4.8 ± 0.6 ml/100 g in Fast O2 Delivery. Thus the faster VO2 on-kinetics in Fast O2 Delivery resulted in an ~30% reduction in the O2 deficit compared with that observed in Control.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The main finding of the present study was that, in the isolated dog gastrocnemius in situ, during transitions from rest to electrically stimulated contractions corresponding to the muscle VO2 peak, abolishment of delays in convective O2 delivery to muscle resulted in significantly faster muscle VO2 on-kinetics. This suggests that, for transitions involving contractions of high-metabolic intensity, convective O2 delivery plays a role as a limiting factor for VO2 on-kinetics.

In previous studies conducted utilizing the same preparation but involving transitions from rest to contractions of lower metabolic intensity (~60% of VO2 peak), our laboratory showed that convective O2 delivery (as well as peripheral O2 diffusion) did not play a role as limiting factors for the VO2 on-kinetics (9, 10). On the other hand, studies conducted in exercising humans suggested that, for exercise higher than the ventilatory threshold, enhanced O2 delivery to muscle may indeed determine faster VO2 on-kinetics, which is at variance with observations for transitions involving exercise of lower metabolic intensities (8, 11, 19). The results of the present study, in conjunction with those mentioned above (8, 9, 11, 19), suggest that the issue of O2 delivery or O2 utilization as the main limiting factor for the VO2 on-kinetics (see, e.g., Refs. 3-5, 14, 21, 28, 31) might lead to partially different conclusions, depending on the intensity of the exercise (or contractions) involved in the transition. More specifically, for transitions to exercise (or contractions) of low-metabolic intensity, the limiting factor would be represented by an inertia of muscle oxidative metabolism, whereas for transitions to exercise (or contractions) of high-metabolic intensity, O2 delivery would contribute, together with the inertia of oxidative metabolism, in determining the VO2 on-kinetics. All of this appears quite reasonable, in physiological terms, considering that, during contractions close to or at VO2 peak, the mechanisms responsible for convective O2 delivery to muscle [which is known to be the main limiting factor for maximum VO2 (see, e.g., Ref. 30)] must be stressed to a greater extent than during contractions of lower metabolic intensity.

The VO2 on-kinetics in Fast O2 Delivery [i.e., after eliminating possible restraints by convective O2 delivery and presumably also by intramuscular Q/VO2 maldistribution (see below)] was faster than in Control, but the adjustment to the new steady state still followed a time course characterized by a half-time of ~12.5 s. As shown in Fig. 2, a complete dissociation of the independent variable, i.e., of O2 delivery to muscle (as represented by Q), in the two experimental conditions, determined only a relatively minor change in the dependent variable, i.e., of VO2. CaO2 - CvO2 was slightly slower to adjust to the new steady state in Fast O2 Delivery than in Control, suggesting an intrinsic limitation of the rate at which muscle can utilize the delivered O2. An inertia in the adjustment of skeletal muscle oxidative phosphorylation to the new metabolic level could be determined by levels of cellular metabolic controllers (see, e.g., Refs. 4, 21, 31) and/or enzyme activation (see, e.g., Ref. 27). Other factors potentially responsible could be the following. 1) There could be a limitation in O2 delivery to muscle fibers related to peripheral O2 diffusion. The latter has been shown not to be a limiting factor for VO2 kinetics during transitions from rest to 60% of VO2 peak (10), but the situation could be different during transitions from rest to contractions of higher metabolic intensity, because it is known that peripheral O2 diffusion represents one of the limiting factors for maximum VO2 (see, e.g., Ref. 30). 2) There could be methodological factors related to the fact that VO2 was necessarily determined across the muscle and not inside of it, where gas exchange occurs. Van Beek and Westerhof (29) applied mathematical methods to their isolated rabbit heart experimental model to account for O2 diffusive and vascular transport delays in the interpretation of the observed venous O2 concentration transients during step changes in heart rate. The resulting "mitochondrial" VO2 response time was significantly faster than that of VO2 determined across the whole heart (29). 3) There could be utilization of myoglobin (Mb) O2 stores. O2 stored with Mb could indeed contribute to oxidative metabolism early during the transition (7), and the resulting VO2 would not of course be detected by our measurements, which were carried out across the muscle. However, the contributions of Mb O2 stores, with respect to the measured VO2 across muscle, should be small. Assuming a Mb concentration of ~7 g/kg of dog muscle (22), Mb O2 stores in 80 g of muscle would be ~0.7 ml of O2. By assuming a 50% Mb desaturation, occurring "early" (first minute) during the contraction period (25), this would correspond to a VO2 of only ~0.3-0.4 ml · min-1 · 100 g-1.

It is well known that there is spatial heterogeneity of Q within active muscle (23), but at present it is not known whether this corresponds to VO2 heterogeneity. Q/VO2 maldistribution within muscle could, in theory, influence the VO2 on-kinetics by determining areas of tissue anaerobiosis. In our experimental model, all muscle fibers were synchronously activated by electrical stimulation so that VO2 heterogeneity was presumably absent or significantly reduced compared with the situation of asynchronous and heterogeneous fiber activation in physiologically contracting muscle. This aspect represents an intrinsic limitation of the present experimental model. In Fast O2 Delivery, this absent or reduced VO2 heterogeneity was associated with high Q and with vasodilation induced by adenosine. Thus, if any Q/VO2 maldistribution was present in Control, it must have been significantly reduced or eliminated in Fast O2 Delivery. In theory, this could be one factor causing the faster VO2 on-kinetics observed in Fast O2 Delivery.

Analysis of TDp and tau p for VO2, Q, and CaO2 - CvO2 obtained in the present study shows interesting similarities with homologous data obtained by Grassi et al. (12) in exercising legs in humans. Both in the present study (Control condition) and in that study, indeed, Q increased immediately at the contraction's onset, following a substantially exponential time course, whereas CaO2 - CvO2 showed a "biphasic" time course in which a TD of several seconds was followed by a very rapid exponential increase to the new steady state. As mentioned before, in the present study this exponential increase was slower in the presence of an excess of delivered O2 (i.e., in Fast O2 Delivery).

In our laboratory's previous paper (9), we observed, in the Control condition, a faster Q on-kinetics compared with VO2 on-kinetics. In the present study, TD + tau  of Q on-kinetics and VO2 on-kinetics was substantially the same. This observation should provide further (although indirect) support for the concept that, for the type of transition investigated in the present study, convective O2 delivery to muscle is one of the limiting factors for the VO2 on-kinetics.

TD + tau  for the primary component of the VO2 on-kinetics in Control (~23 s), in the present study, appears remarkably similar to the t63% VO2 on-kinetics value observed in our laboratory's previous work (9) dealing with transitions to ~60% of VO2 peak (in which no slow component was observed), thus suggesting constancy of the primary component of the VO2 on-kinetics in the isolated dog gastrocnemis in situ at different metabolic outputs.

In 9 out of 10 experiments (see Fig. 3), a slow component of the VO2 response was observed. To our knowledge, this is the first time that such component was observed in this preparation. Possible mechanistic bases for the VO2 slow component, its physiological significance, and its consequences for exercise capacity were discussed in several recent studies and reviews (see, e.g., Ref. 6). As discussed above, in the present study the faster VO2 on-kinetics observed in Fast O2 Delivery was essentially due to a faster "primary" (32) response.

Faster VO2 on-kinetics in Fast O2 Delivery resulted in an ~30% reduction in the calculated O2 deficit compared with Control. A faster adjustment of skeletal muscle oxidative metabolism during increases in metabolic demand reduces the need for substrate level phosphorylation, with lesser disturbance of cellular and organ homeostasis (lower degradation of phosphocreatine and glycogen stores, lower accumulation of lactate and H+) and obvious implications for work performance and muscle fatigue. In the present study, muscle fatigue was indeed less in Fast O2 Delivery than in Control. In theory, higher force production (less muscle fatigue) in Fast O2 Delivery could be associated with a higher ATP demand and, therefore, with higher VO2, thereby possibly influencing the comparison of VO2 kinetics in the two experimental conditions. Against this possibility is the observation of very similar VO2 values at steady state during contractions in the two conditions. According to Gaesser and Poole (6), complexities associated with the VO2 slow component may confound accurate calculation and interpretation of the O2 deficit. Critical for such calculation is the assumption that the O2 requirement for exercise is known. In the present study, as a first approximation, we assumed that the O2 requirement for contractions corresponded to the asymptotic VO2 value at the end of the contraction period. This assumption cannot be directly tested. However, because the amplitudes of both the primary and the slow components of the VO2 response were not different in the two conditions, and because we were mainly interested in comparing the O2 deficit between the two conditions, we believe that such comparison was substantially correct.

Advantages and limitations of the present preparation (isolated dog gastrocnemius in situ) for the study of VO2 on-kinetics were discussed at length in our laboratory's previous studies (9, 10). In short, the main disadvantages are represented by the unphysiological contraction pattern (synchronous tetanic contractions), by the intrinsic invasiveness of the preparation, and by the problem of extrapolating the results to exercising humans. Whereas caution is warranted in this respect, it must be noted that 1) basic mechanisms of regulation of oxidative phosphorylation appear the same across mammalian species (2), and 2) the patterns of Q and VO2 increase at contraction onset appear remarkably similar in canine [as shown by the present and by previous studies (see, e.g., Ref. 9)] and in human muscles (see, e.g., Refs. 12, 15), with the only difference being faster kinetics in dogs, presumably as a consequence of the higher percentage of oxidative fibers (20). On the other hand, the experimental model offers the obvious advantages of allowing the manipulation (and a direct measurement) of O2 delivery to the contracting muscle, as well as the measurement of VO2 directly across the muscle. Resting Q to muscle was higher, and O2 extraction was lower, than the values usually observed in skeletal muscle (see, e.g., Ref. 18). The elevated resting Q is likely attributable to some loss of vascular tone related to the surgical denervation of the muscle (18). It must be noted, however, that the proposed mechanisms determining and regulating the increase in muscle Q at the onset of contractions (muscle pump, "myogenic" control, "propagated vasodilation," endothelium-derived vasodilation, increased concentration of metabolites in the interstitium) (18) would be unaffected by the surgical denervation of the muscle. As pointed out above, indeed, the time course of Q increase during the transition, as described in the present study, appears remarkably similar to that observed in human studies (see, e.g., Refs. 12, 15, 24). In strict terms, however, it cannot be excluded that the magnitude of increase in the VO2 on-kinetics observed in Fast O2 Delivery (vs. Control) in the present study might have been even greater if muscles had not been relatively hyperperfused in Control. Caution in the extrapolation of the present data to exercising humans should derive also from the fact that, in our Control condition, the relative hyperperfusion of muscle and the likely reduction of VO2/Q heterogeneity might cause higher intracellular PO2 values at rest and at the onset of contractions, compared with that observed in humans.

Although we employed stimulation parameters that have been associated with the highest VO2 values ever reported for this muscle preparation (1, 16), our VO2 peak values were considerably lower than those reported by those investigators (1, 16). One possible reason for this result is the requirement of contralateral perfusion through tubing and a pump in the present study, as well as in those performed over the years by the San Diego group (see, e.g., Ref. 13). Therefore, it remains possible that the conclusions of the present study are peculiar to these experimental conditions.

In conclusion, in previous studies our laboratory showed that, in the isolated dog gastrocnemius in situ, during transitions from rest to ~60% of VO2 peak, convective O2 delivery and peripheral O2 diffusion do not represent limiting factors for the VO2 on-kinetics, which, therefore, appears mainly set by an inertia of muscle oxidative metabolism (9, 10). In the present study, we showed that the situation was different during transitions to higher metabolic intensity, i.e., from rest to the muscle VO2 peak. In this case, indeed, elimination of all delays in convective O2 delivery to muscle during the transition resulted in faster VO2 on-kinetics, in a lower O2 deficit, and in less muscle fatigue. This demonstrates that, during transitions to contractions at VO2 peak, convective O2 delivery contributes, together with an inertia of oxidative metabolism, in determining the VO2 on-kinetics. The limiting factors for muscle VO2 on-kinetics are at least in part different, depending on the intensity of the metabolic transition.


    ACKNOWLEDGEMENTS

This study was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants 1RO1-AR-40342 and AR-40155, by NATO Collaborative Research Grant 972111, and by Telethon-Italy Grant 1161C.


    FOOTNOTES

Address for reprint requests and other correspondence: B. Grassi, ITBA-CNR, Palazzo LITA, Via Fratelli Cervi 93, I-20090 Segrate (MI), Italy (E-mail: grassi{at}itba.mi.cnr.it).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 27 August 1999; accepted in final form 1 May 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Ameredes, BT, Brechue WF, and Stainsby WN. Mechanical and metabolic determination of VO2 and fatigue during repetitive isometric contractions in situ. J Appl Physiol 84: 1909-1916, 1998[Abstract/Free Full Text].

2.   Balaban, RS. Regulation of oxidative phosphorylation in the mammalian cell. Am J Physiol Cell Physiol 258: C377-C389, 1990[Abstract/Free Full Text].

3.   Barstow, TJ, Lamarra N, and Whipp BJ. Modulation of muscle and pulmonary O2 uptakes by circulatory dynamics during exercise. J Appl Physiol 68: 979-989, 1990[Abstract/Free Full Text].

4.   Cerretelli, P, and di Prampero PE. Gas exchange in exercise. In: Handbook of Physiology. The Respiratory System. Gas Exchange. Bethesda, MD: Am. Physiol. Soc, 1987, sect. 3, vol. IV, chapt. 16, p. 297-339.

5.   Cerretelli, P, Rennie DW, and Pendergast DR. Kinetics of metabolic transients during exercise. In: Exercise Bioenergetics and Gas Exchange, edited by Cerretelli P, and Whipp BJ.. Amsterdam, The Netherlands: Elsevier, 1980, p. 187-209.

6.   Gaesser, GA, and Poole DC. The slow component of oxygen uptake kinetics in humans. In: Exercise and Sport Sciences Reviews, edited by Holloszy JO.. Baltimore, MD: Williams & Wilkins, 1996, vol. 24, p. 35-71.

7.   Gayeski, TEJ, Connett RJ, and Honig CR. Oxygen transport in rest-work transition illustrates new functions for myoglobin. Am J Physiol Heart Circ Physiol 248: H914-H921, 1985[Abstract/Free Full Text].

8.   Gerbino, A, Ward SA, and Whipp BJ. Effects of prior exercise on pulmonary gas-exchange kinetics during high-intensity exercise in humans. J Appl Physiol 80: 99-107, 1996[Abstract/Free Full Text].

9.   Grassi, B, Gladden LB, Samaja M, Stary CM, and Hogan MC. Faster adjustment of O2 delivery does not affect VO2 on-kinetics in isolated in situ canine muscle. J Appl Physiol 85: 1394-1403, 1998[Abstract/Free Full Text].

10.   Grassi, B, Gladden LB, Stary CM, Wagner PD, and Hogan MC. Peripheral O2 diffusion does not affect VO2 on-kinetics in isolated in situ canine muscle. J Appl Physiol 85: 1404-1412, 1998[Abstract/Free Full Text].

11.   Grassi, B, Marconi C, Meyer M, Rieu M, and Cerretelli P. Gas exchange and cardiovascular kinetics with different exercise protocols in heart transplant recipients. J Appl Physiol 82: 1952-1962, 1997[Abstract/Free Full Text].

12.   Grassi, B, Poole DC, Richardson RS, Knight DR, Erickson BK, and Wagner PD. Muscle O2 uptake kinetics in humans: implications for metabolic control. J Appl Physiol 80: 988-998, 1996[Abstract/Free Full Text].

13.   Hogan, MC, Bebout DE, Wagner PD, and West JB. Maximal O2 uptake of in situ dog muscle during acute hypoxemia with constant perfusion. J Appl Physiol 69: 570-576, 1990[Abstract/Free Full Text].

14.   Hughson, RL. Exploring cardiorespiratory control mechanisms through gas exchange dynamics. Med Sci Sports Exerc 22: 72-79, 1990[ISI][Medline].

15.   Hughson, RL, Shoemaker JK, Tschakovsky ME, and Kowalchuck JM. Dependence of muscle VO2 on blood flow dynamics at onset of forearm exercise. J Appl Physiol 81: 1619-1626, 1996[Abstract/Free Full Text].

16.   Kelley, KM, Hamann JJ, Aschenbach WG, and Gladden LB. Canine gastrocnemius muscle in situ: VO2 max (Abstract). Med Sci Sports Exerc 28: S62, 1996.

17.   Kurdak, SS, Hogan MC, and Wagner PD. Adenosine infusion does not improve maximal O2 uptake in isolated working dog muscle. J Appl Physiol 76: 2820-2824, 1994[Abstract/Free Full Text].

18.   Laughlin, MH, Korthuis RJ, Duncker DJ, and Bache RJ. Control of blood flow to cardiac and skeletal muscle during exercise. In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 12, chapt. 16, p. 705-769.

19.   MacDonald, M, Pedersen PK, and Hughson RL. Acceleration of VO2 kinetics in heavy submaximal exercise by hyperoxia and prior high-intensity exercise. J Appl Physiol 83: 1318-1325, 1997[Abstract/Free Full Text].

20.   Maxwell, LC, Barclay JK, Mohrman DE, and Faulkner JA. Physiological characteristics of skeletal muscles of dogs and cats. Am J Physiol Cell Physiol 233: C14-C18, 1977[Abstract/Free Full Text].

21.   Meyer, RA, and Foley JM. Cellular processes integrating the metabolic response to exercise. In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 12, chapt. 18, p. 842-869.

22.   Millikan, GA. Muscle hemoglobin. Physiol Rev 19: 503-523, 1939[Free Full Text].

23.   Piiper, P, Pendergast DR, Marconi C, Meyer M, Heisler N, and Cerretelli P. Blood flow distribution in dog gastrocnemius muscle at rest and during exercise. J Appl Physiol 58: 2068-2074, 1985[Abstract/Free Full Text].

24.   Rådegran, G, and Saltin B. Muscle blood flow at onset of dynamic exercise in humans. Am J Physiol Heart Circ Physiol 274: H314-H322, 1998[Abstract/Free Full Text].

25.   Richardson, RS, Noyszewski EA, Kendrick KF, Leigh JS, and Wagner PD. Myoglobin O2 desaturation during exercise. Evidence of limited O2 transport. J Clin Invest 96: 1916-1926, 1995.

26.   Stainsby, WN, and Welch HG. Lactate metabolism of contracting dog skeletal muscle in situ. Am J Physiol 211: 177-183, 1966.

27.   Timmons, JA, Gustafsson T, Sundberg CJ, Jansson E, and Greenhaff PL. Muscle acetyl group availability is a major determinant of oxygen deficit in humans during submaximal exercise. Am J Physiol Endocrinol Metab 274: E377-E380, 1998[Abstract/Free Full Text].

28.   Tschakovsky, ME, and Hughson RL. Interaction of factors determining oxygen uptake at the onset of exercise. J Appl Physiol 86: 1101-1113, 1999[Abstract/Free Full Text].

29.   Van Beek, JHGM, and Westerhof N. Response time of cardiac mitochondrial oxygen consumption to heart rate steps. Am J Physiol Heart Circ Physiol 260: H613-H635, 1991[Abstract/Free Full Text].

30.   Wagner, PD. Muscle O2 transport and O2 dependent control of metabolism. Med Sci Sports Exerc 27: 47-53, 1995[ISI][Medline].

31.   Whipp, BJ, and Mahler M. Dynamics of pulmonary gas exchange during exercise. In: Pulmonary Gas Exchange, edited by West JB.. New York: Academic, 1980, vol. II, p. 33-96.

32.   Whipp, BJ, and Ward SA. Physiological determinants of pulmonary gas exchange kinetics during exercise. Med Sci Sports Exerc 22: 62-71, 1990[ISI][Medline].


J APPL PHYSIOL 89(4):1293-1301
8750-7587/00 $5.00 Copyright © 2000 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
S. Koga, D. C. Poole, L. F. Ferreira, B. J. Whipp, N. Kondo, T. Saitoh, E. Ohmae, and T. J. Barstow
Spatial heterogeneity of quadriceps muscle deoxygenation kinetics during cycle exercise
J Appl Physiol, December 1, 2007; 103(6): 2049 - 2056.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. Lai, G. M. Saidel, B. Grassi, L. B. Gladden, and M. E. Cabrera
Model of oxygen transport and metabolism predicts effect of hyperoxia on canine muscle oxygen uptake dynamics
J Appl Physiol, October 1, 2007; 103(4): 1366 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. Burnley, C. L. Roberts, R. Thatcher, J. H. Doust, and A. M. Jones
Influence of blood donation on O2 uptake on-kinetics, peak O2 uptake and time to exhaustion during severe-intensity cycle exercise in humans
Exp Physiol, May 1, 2006; 91(3): 499 - 509.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. Grassi, M. C Hogan, K. M Kelley, R. A Howlett, and L. B. Gladden
Effects of nitric oxide synthase inhibition by L-NAME on oxygen uptake kinetics in isolated canine muscle in situ
J. Physiol., November 1, 2005; 568(3): 1021 - 1033.
[Abstract] [Full Text] [PDF]